<ul data-eligibleForWebStory="true"><li>Abridge, an AI startup automating medical notes, secures $300 million in Series E funding at a valuation of $5.3 billion.</li><li>The round was led by Andreessen Horowitz with participation from Khosla Ventures, following a previous fundraise in February at a $2.75 billion valuation.</li><li>Abridge, founded 7 years ago, is a leader in the AI-powered medical scribe market, known for its integration with Epic Systems, a prominent health record software.</li><li>In Q1, Abridge reached $117 million in contracted annual recurring revenue, showcasing significant growth and adoption in the market.</li><li>The company also announced an expansion into converting medical notes into AI-powered medical codes, positioning itself against competitors like CodaMetrix.</li><li>Abridge's technology is utilized by over 150 major health systems in the U.S., demonstrating widespread adoption within the healthcare industry.</li></ul>

In just 4 months, AI medical scribe Abridge doubles valuation to $5.3B

Discover more